Evidence map›Paper›PMID 32670897›Full record

ArticleFrontiers in cellular and infection microbiology2020

Chukwuemeka Samson Ahamefule, Qijian Qin, Arome Solomon Odiba, Siqiao Li, Anene N Moneke, James C Ogbonna, Cheng Jin, Bin Wang, Wenxia Fang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Key sugar transporters drive development and pathogenicity inFrontiers in cellular and infection microbiology · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. TheMicrobiology spectrum · 2022
    Article
  11. Article
  12. Evaluation ofFrontiers in pharmacology · 2022
    Article
  13. Article
  14. Article
  15. Frontiers in cellular and infection microbiology · 2021
    Review
  16. Combination Therapy to Treat Fungal Biofilm-Based Infections.International journal of molecular sciences · 2020
    Review
  17. Marine Bioactive Compounds againstAntibiotics (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Chukwuemeka Samson AhamefuleNational Engineering Research Center for Non-food Biorefinery, Guangxi Academy of Sciences, Nanning, China.
Qijian QinNational Engineering Research Center for Non-food Biorefinery, Guangxi Academy of Sciences, Nanning, China.
Arome Solomon OdibaNational Engineering Research Center for Non-food Biorefinery, Guangxi Academy of Sciences, Nanning, China.
Siqiao LiState Key Laboratory of Non-food Biomass and Enzyme Technology, Guangxi Academy of Sciences, Nanning, China.
Anene N MonekeDepartment of Microbiology, University of Nigeria, Nsukka, Nigeria.
James C OgbonnaDepartment of Microbiology, University of Nigeria, Nsukka, Nigeria.
Cheng JinNational Engineering Research Center for Non-food Biorefinery, Guangxi Academy of Sciences, Nanning, China.
Bin WangNational Engineering Research Center for Non-food Biorefinery, Guangxi Academy of Sciences, Nanning, China.
Wenxia FangNational Engineering Research Center for Non-food Biorefinery, Guangxi Academy of Sciences, Nanning, China.
Guangxi Academy of Sciences · CNUniversity of Nigeria · NGGuangxi University · CN

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
NIH HHS P40 OD010440
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AspergillosisPharmaceutical PreparationsAnimalsAntifungal AgentsAspergillus fumigatusCaenorhabditis elegansVirulenceAntifungal AgentsPharmaceutical PreparationsAspergillus fumigatusCaenorhabditis eleganshyphal filamentationinfection modelpathogenicity

Identifiers

PMID32670897
PMCPMC7332887
OpenAlexW3037589881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.